1.

Record Nr.

UNINA9910810938703321

Autore

Källén Bengt

Titolo

Drugs during pregnancy [[electronic resource] /] / Bengt Källén

Pubbl/distr/stampa

New York, : Nova Biomedical Books, c2009

ISBN

1-61728-374-6

Edizione

[1st ed.]

Descrizione fisica

1 online resource (464 p.)

Collana

Pregnancy and infants : medical, psychological and social issues series

Disciplina

618.3/2

Soggetti

Fetus - Effect of drugs on

Pregnant women - Drug use

Lingua di pubblicazione

Inglese

Formato

Materiale a stampa

Livello bibliografico

Monografia

Note generali

Description based upon print version of record.

Nota di bibliografia

Includes bibliographical references and index.

Nota di contenuto

Intro -- Library of Congress Cataloging-in-Publication Data -- Contents -- Preface -- Abbreviations Used -- Chapter 1 -- A Short history of the study of maternal drug Use and delivery outcome -- The alert clinician -- Epidemiological studies -- References -- Chapter 2 -- The practical consequences of drug effects on delivery outcome -- 1. Introduction of a New drug into a market -- 2. A woman has Used the drug in early pregnancy -- 3. To prescribe a drug to a pregnant woman -- 4. A malformed infant was born and the mother remembers Having Taken a specific drug. -- A causal effect? -- Chapter 3 -- The Swedish health registers used  and variables studied -- The following records are included: -- MHV1 -- MHV2 -- FV1 -- FV2 -- The following data were used -- Year of delivery -- Maternal age -- Parity -- Smoking in early pregnancy -- Number of previous miscarriages -- Body Mass Index (BMI) -- Country of birth -- Family situation -- Work outside home -- Maternal education -- Maternal drug use -- Multiple births -- Maternal delivery diagnoses -- Delivery mode -- Pregnancy duration in completed weeks -- Infant sex -- Birth weight in gram -- Intrauterine growth -- Infant neonatal diagnoses -- Low Apgar score -- Congenital malformations in infants -- Any congenital malformation -- Chapter 4 -- Advantages and disadvantages of the study material -- Advantages -- Disadvantages -- Exposure information -- Outcome information -- Information on confounding factors -- References -- Chapter 5 -- Strategy of analysis -- Statistical notes -- References -- Chapter 6 -- Data on women and infants recorded in the Medical Birth Register



during -- 1996-2005 -- Data on pregnancy outcome in all deliveries in the Medical Birth Register during 1996-2005 -- 1. Preterm birth, low birth weight, large birth weight, intrauterine growth -- 2. Infant sex and multiple births.

3. Maternal and infant diagnoses and infant outcome -- 4. Congenital malformations -- Chapter 7 -- Antacids -- Characteristics of women Using antacids -- Outcome after maternal Use of antacids -- Infant sex -- Multiple births -- Summary -- References -- Chapter 8 -- Drugs Used for gastric ulcer and gastro-oesophageal reflux -- Characteristics of women Using drugs for gastric ulcer or gastro-oesophageal reflux -- Outcome after maternal Use of drugs for stomach ulcer or gastro-oesophageal reflux -- Infant sex -- Multiple births -- Sucralfate -- Effects of concomitant drug use -- Summary -- References -- Chapter 9 -- Drugs Used for functional intestinal symptoms -- Characteristics of women Using drugs  for functional intestinal symptoms -- Outcome after maternal Use of drugs  for functional intestinal symptoms -- Infant sex -- Multiple births -- Summary -- References -- Chapter 10 -- Anti-Emetic drugs -- Outcome after maternal Use of antiemetic drugs -- Infant sex -- Multiple births -- Summary -- References -- Chapter 11 -- Bile acid preparations -- Outcome after maternal Use of Bile Acid preparations -- Infant sex -- Multiple birth -- Infant mortality -- Summary -- Chapter 12 -- Laxatives -- Characteristics of women Using laxatives -- Outcome after maternal Use of laxatives -- Infant sex -- Multiple births -- Summary -- References -- Chapter 13 -- Drugs Used as antidiarrhoics, intestinal anti-Infectives,  or at inflammatory bowel disease -- Characteristics for women Using drugs as antidiarrhoics, intestinal anti-infectives,  or at inflammatory bowel disease -- Outcome after maternal use of drugs Used as antidiarrhoics, intestinal anti-infectives,  or at inflammatory bowel disease -- Infant sex -- Multiple births -- Summary -- References -- Chapter 14 -- Anti-Obesity drugs -- Characteristics of women Using anti-Obesity drugs.

Outcome after maternal Use of anti-Obesity drugs -- Infant sex -- Multiple births -- Infant mortality -- Summary -- References -- Chapter 15 -- Digestives, including enzymes -- Characteristics of women Using digestive drugs -- Outcome after maternal Use of digestive drugs -- Infant sex -- Multiple births -- Infant mortality -- Summary -- References -- Chapter 16 -- Drugs for diabetes -- Characteristics of women Using antidiabetic drugs -- Outcome after maternal Use of antidiabetic drugs -- Infant sex -- Multiple births -- Summary -- References -- Chapter 17 -- Vitamins and minerals -- Characteristics of women Using vitamins  or minerals -- Outcome after maternal Use of vitamins  and minerals -- Infant sex -- Multiple births -- Summary -- References -- Chapter 18 -- Anabolic steroids -- Summary -- References -- Chapter 19 -- Anticoagulants -- Characteristics of women Using  anticoagulant drugs -- Outcome after maternal Use of anticoagulants -- Infant sex -- Multiple births -- Summary -- References -- Chapter 20 -- Haemostatics -- Characteristics of women Using Haemostatics -- Outcome after maternal Use of haemostatics -- Infant sex -- Multiple births -- Infant mortality -- K-vitamin -- Summary -- References -- Chapter 21 -- Vitamin B12 and folic acid -- Characteristics of women Using vitamin B12  or folic acid -- Outcome after maternal Use of vitamin B12  or folic acid -- Infant sex -- Multiple births -- Summary -- References -- Chapter 22 -- Drugs for cardiac diseases -- Characteristics of women Using drugs  for cardiac diseases -- Outcome after maternal Use of cardiac drugs -- Infant sex -- Multiple births -- Infant mortality -- Summary -- References -- Chapter 23 -- Antihypertensives --



Characteristics of women Using drugs  for antihypertensives -- Outcome after maternal Use of antihypertensives -- Infant sex -- Multiple births -- Summary.

References -- Chapter 24 -- Diuretics -- Characteristics of women Using diuretics -- Outcome after maternal Use of diuretics -- Infant sex -- Multiple births -- Summary -- References -- Chapter 25 -- Serum lipid reducing agents -- Characteristics of women Using lipid  reducing drugs -- Outcome after maternal Use of lipid reducing drugs -- Infant sex -- Multiple births -- Infant mortality -- Summary -- References -- Chapter 26 -- Dermatological drugs -- Characteristics of women Using  dermatological drugs -- Outcome after maternal Use  of dermatological drugs -- Infant sex -- Multiple births -- Topical corticosteroids -- Other dermatological drugs -- Summary -- References -- Chapter 27 -- Gynaecological drugs -- Characteristics of women Using anti-infectives  or antiseptics vaginally -- Outcome after maternal Use of anti-infectives  or antiseptics vaginally -- Infant sex -- Multiple births -- Summary -- References -- Chapter 28 -- Prolactine inhibitors and dopamine agonists -- Characteristics of women Using prolactine inhibitors or dopamine agonists -- Outcome after maternal Use of prolactine inhibitors or dopamine agonists -- Infant sex -- Multiple births -- Infant mortality -- Summary -- References -- Chapter 29 -- Oral contraceptives -- Characteristics of women Using oral contraceptives in early pregnancy -- Outcome after maternal Use of oral contraceptives in early pregnancy -- Infant sex -- Multiple births -- Summary -- References -- Chapter 30 -- Sex hormones Other than oral contraceptives -- Characteristics of women Using progestogen drugs -- Outcome after maternal Use of progestogens -- Infant sex -- Multiple births -- Summary -- References -- Chapter 31 -- Ovulation stimulants -- Characteristics of women Using ovarian stimulants -- Outcome after maternal Use of ovarian stimulants -- Infant sex -- Multiple births -- Summary -- References.

Chapter 32 -- Urologicals -- Characteristics of women using urological drugs -- Outcome after maternal Use of urologics -- Infant sex -- Multiple births -- Summary -- Chapter 33 -- Hypophyseal and hypothalamic hormones (except gonadotrophines) and analogues -- Characteristics of women Using hypophyseal  or hypothalamic drugs -- Outcome after maternal Use of hypophyseal hormones other than gonadotrophines -- Infant sex -- Multiple births -- Summary -- References -- Chapter 34 -- Corticosteroids Used systemically -- Characteristics of women Using glucocorticoids -- Outcome after maternal Use  of glucocorticosteroids -- Infant sex -- Multiple births -- Summary -- References -- Chapter 35 -- Thyroid drugs -- Characteristics of women Using thyroid drugs -- Thyroid hormones -- Thyreostatics -- Outcome after maternal Use of thyroid drugs -- Infant sex -- Multiple births -- Summary -- References -- Chapter 36 -- Antibiotics Used systemically -- Characteristics of women Using antibiotics -- Outcome after maternal Use of antibiotics -- Infant sex -- Multiple births -- Trimethoprim -- Quinolone derivatives -- Summary -- References -- Chapter 37 -- Antimycotics Used systemically -- Characteristics of women Using systemic antimycotics -- Outcome after maternal Use of systemic antimycotics -- Infant sex -- Multiple births -- Infant mortality -- Summary -- References -- Chapter 38 -- Tuberculostatic drugs -- Characteristics of women Using  tuberculostatic drugs -- Outcome after maternal Use of  tuberculostatic drugs -- Infant sex -- Multiple births -- Infant mortality -- Pregnancy duration and infant birth weight at maternal use of tuberculostatic drugs -- Summary -- References -- Chapter 39 -- Anti-Virus drugs -- Characteristics of women Using antivirus drugs -- Outcome after



maternal Use of antivirus drugs -- Infant sex -- Multiple births -- Summary -- References.

Chapter 40.